Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Hikma Pharmaceuticals PLC

+ Add to Watchlist

HKMPY:US

65.6901 USD 5.6801 9.47%

As of 20:10:02 ET on 05/15/2015.

Snapshot for Hikma Pharmaceuticals PLC (HKMPY)

Open: 65.5201 Day's Range: 65.4500 - 66.5900 Volume: 5,038
Previous Close: 60.0100 52wk Range: 54.1400 - 79.0670 1-Yr Rtn: -

Stock Chart for HKMPY

No chart data available.
  • HKMPY:US 65.6901
  • 1D
  • 1M
  • 1Y
60.0100
Interactive HKMPY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HKMPY

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 23.4273
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) 2.8040
Est. PEG Ratio 1.2643
Market Cap (M USD) 6,532.22
Shares Outstanding (M) 99.44
30 Day Average Volume 196
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.96%
Cash Dividend (USD) 0.6325
Dividend Ex-Date 04/15/2015
5 Year Dividend Growth -
Next Earnings Announcement 08/19/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HKMPY

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HKMPY

Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on developing, manufacturing, and marketing a range of both branded and non-branded generic and in-licensed pharmaceutical products. The Company's operations are conducted in the United States, the Middle East, and North Africa region, as well as Europe.

Said Sameeh Talib DarwazahChairman/CEOMazen Samih Taleb DarwazahVice Chairman/Pres & CEO:MENA
Michael Raya "Mike"President & CEO:USAKhalid NabilsiChief Financial Officer
More Company Profile & Key Executives for HKMPY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil